Borreliella spielmanii DbpA

Added to your cart

Borreliella spielmanii DbpA

Cart subtotal: £0.00

View cart (0) Checkout

#SKU 42900

Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

DbpA, also named p17 or Osp17, is a diagnostically relevant but heterogeneous protein among the human pathogenic B. burgdorferi sensu lato species. It has been shown that integration in serologic borreliosis assays significantly improves sensitivity of IgG and IgM detection in patient sera.
0.1 mg

More information



  • Shipping Information
  • Dry ice
  • Abbreviations
  • B. spielmanii DbpA
  • Recommended Use
  • RUO
  • Storage
  • -70°C or below
  • Shelf Life
  • 5 years from DOM
  • Disease Area
  • Borreliosis/Lyme Disease
  • Source
  • E. coli

Technical Documents

MSDS Bs DbpA 42900 210426 Rev03 (56.01KB)

Product Specification (24.05KB)

Safety Data Sheet (56.01KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands


The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.


Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.


Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox